What Does the CMS 2024 Final Rule Mean for You?
Each year the Centers for Medicare and Medicaid Services review proposed changes to the Medicare program. The CMS 2024 final rule will most impact agents and third-party marketing organizations. The 2024 final rule requires a minimum 48-hour window between a Scope of Appointment form being completed and an appointment taking place. It also limits how
Is the Federal Government Cutting Medicare Advantage?
More than 60 million seniors and disabled individuals lean on Medicare for healthcare coverage. Potential cuts to Medicare Advantage remain a high-priority talking point between Democrats and Republicans. Let’s dive further into the proposed rule changes regarding cutting Medicare Advantage and what it may mean for you. Cutting Medicare Advantage: Do the proposed changes strengthen
The State of Medicare & Social Security
Medicare and Social Security are federal government programs offering Americans some reassurance and a safety net through retirement or disabilities. Both programs are very similar but very different. Below we’ll review the current state of Medicare and Social Security and what it means for you. Current State of Medicare and Social Security Medicare currently provides
What does it Mean to Sunset Social Security and Medicare?
The Social Security and Medicare programs are two of the most critical safety nets for American seniors. So when President Biden said that Republicans want to “sunset” these programs, it caused quite a stir. But what does it mean to sunset Social Security and Medicare? Let’s take a closer look. Sunset Medicare and Social Security:
Why Medicare Won’t Cover Paxlovid
Paxlovid is an experimental oral COVID-19 treatment, and as with other experimental treatments, it’s not covered by Medicare. This is because Medicare does not cover any experimental treatments that have not been proven to be safe and effective. Therefore, if you are seeking therapy for COVID-19, you may not be able to have Paxlovid covered
How the Leqembi FDA Approval Affect Medicare Beneficiaries
The Food and Drug Administration has provided approval of Leqembi as a treatment option for mild to moderate Alzheimer’s disease. It works by blocking a specific enzyme responsible for the production of amyloid beta, a protein responsible for forming plaques in the brain, a hallmark of Alzheimer’s disease. Leqembi is the first drug to receive
What to Expect With The Medicare Part B Decreases for 2023
Each year the Centers for Medicare and Medicaid Services review the spending from the federal Medicare Program to project cost changes for the following year. While this is necessary, many Medicare beneficiaries become nervous waiting for the new numbers and expect increases. Fortunately, in 2023, these costs will be lowered from the previous year. We’ll
How the Inflation Reduction Act of 2022 Will Impact Medicare
One of the biggest concerns for Medicare beneficiaries is their prescription drug costs. For some seniors, it’s the difference between life and death. Unfortunately, as inflation runs rampant across the nation, it’s getting harder for them to pay for their medications. Fortunately, this could be better with the changes in the Inflation Reduction Act of
Changes to Medicare HSA Contributions
HSA or Health Savings Accounts are growing more popular every year. The increase in popularity within this style of plan is a result of growing insurance and healthcare costs. More than 32 million HSA accounts are currently active in the United States and receiving contributions. One of the lesser-known items is that you can no
How Price Transparency Would Impact Medicare Beneficiaries
Health care costs are a source of pain and anguish for many Americans. On January 1st. 2021, the Federal Government implemented a new law that went into effect to force hospitals to be more transparent about their charges. So far less than 20% of all hospitals are in compliance with the new rules. There are
